124.6 million Baht, an increase of 4,655 percent from the third quarter of 2018, representing a net profit margin of 4.66 percent. The increased net profit in the third quarter of 2019 was mainly due to
-o-Q and 29.6% Y-o-Y. Following the economic crisis facing the automotive industry due to COVID-19 and lock down measures implemented by many countries in which the Company operates, our customer
increased from previous quarter by 4.24%, mainly due to new spray service, gross profit increasing and selling & administrative expenses decreasing. The company focuses on the sustainable growth, thus, set up
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
¸¡à¸´.ย.2560 WATTANAPAT HOSPITAL TRANG PUBLIC COMPANY LIMITED No. WPH – SET 3/2017 2 October 2017 Subject : Management Discussion and Analysis for Quarter 2 of 2017 ending on 30 June 2017 To
December 2016 due mainly to trade receivables and inventories set to move in response to our growth in business operations. In addition, such increase in total asset also resulted from our investments in
, which is partly due to global economic recovery, as well as the growth in exports of electronic goods which supports Internet of Things (IoT). Private consumption expanded at a moderate pace as overall
subsidiaries had a total revenue of THB 757.67 million, increasing THB 168.88 million, or 28.00%, from the same nine-month period in 2016. The increase in revenue is mainly due to the recovery in the Hard Disk
Phornphan in the amount of Baht 5 million in 2017 and Baht 2 million in February 2018 and the allowance for doubtful accounts was set for EIC Semi in the amount of Baht 1.97 million. 9 . Loss on devaluation
registered share capital. Upon the completion of the transaction, the Company’s shareholding has been diluted from 33.98% to 21.88%, so the Company recognized gain due to the reduction in ownership interest. 4